1. The “Tipping Point” for Breast Cancer Mortality Decline Has Resulted from Size Reductions Due to Mammographic Screening

   • Blake Cady
   • James S. Michaelson
   • Maureen A. Chung

   Breast Oncology 26 January 2011 Pages: 903 - 906

   

2. Alternative Therapy for Breast Cancer: Outcomes, Obstacles and Opportunities

   • Sheldon Marc Feldman

   Breast Oncology 21 January 2011 Pages: 907 - 908

3. Minimizing Morbidity while Preserving Outcome after Inguinal Lymphadenectomy: Navigating between Scylla and Charybdis

   • Vernon K. Sondak
   • Amod A. Sarnaik

   Melanomas 19 January 2011 Pages: 909 - 911

4. Alternative Therapy Used as Primary Treatment for Breast Cancer Negatively Impacts Outcomes

   • Esther Han
   • Nathalie Johnson
   • Kari Steinbock

   Breast Oncology 12 January 2011 Pages: 912 - 916

   

5. Areola and Nipple-Areola-Sparing Mastectomy for Breast Cancer Treatment and Risk Reduction: Report of an Initial Experience in a Community Hospital Setting

   • Jay K. Harness
   • Thomas S. Vetter
   • Arthur H. Salibian

   Breast Oncology Open access 07 October 2010 Pages: 917 - 922

   

6. Perioperative Complications of Breast Cancer Surgery in Elderly Women (≥80 Years)

   • Paraskevi Chatzidaki
   • Chrysovalantis Mellos
   • Ioannis Mylonas

   Breast Oncology 24 November 2010 Pages: 923 - 931

7. Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer

   • Abigail S. Caudle
   • Ana M. Gonzalez-Angulo
   • Funda Meric-Bernstam

   Breast Oncology 09 November 2010 Pages: 932 - 938

   

8. Local Control Following Single-Dose Intraoperative Radiotherapy Prior to Surgical Excision of Early-Stage Breast Cancer

   • Randall J. Kimple
   • Nancy Klauber-DeMore
   • David W. Ollila

   Breast Oncology 09 November 2010 Pages: 939 - 945

   

9. Are We Overtreating Papillomas Diagnosed on Core Needle Biopsy?

   • Amy E. Cyr
   • Deborah Novack
   • Rebecca L. Aft

   Breast Oncology 03 November 2010 Pages: 946 - 951

   

10. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk?

    • Fariha Sheikh
    • Alanna Rebecca
    • Richard J. Gray

    Breast Oncology 16 November 2010 Pages: 952 - 956

    

11. Implementation of a Percutaneous Core Needle Biopsy Training Program: Results from the University of Michigan–Komfo Anokye Teaching Hospital Breast Cancer Research Partnership

    • Baffour Awuah
    • Iman K. Martin
    • Lisa Newman

    Breast Oncology 23 November 2010 Pages: 957 - 960

12. A Phase 2 Study of ^99mTc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer

    • Stanley P. L. Leong
    • Julian Kim
    • Richard C. Orahood

    Melanomas 18 February 2011 Pages: 961 - 969

    

13. A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions

    • Andrew John Spillane
    • Monica Tucker
    • Sandro Pasquali

    Melanomas 14 December 2010 Pages: 970 - 976

    

14. Initial Experience with Videoscopic Inguinal Lymphadenectomy

    • Keith A. Delman
    • David A. Kooby
    • Viraj Master

    Melanomas 24 December 2010 Pages: 977 - 982

    

15. Surgical Approach and Oncologic Outcomes Following Multidisciplinary Management of Retrorectal Sarcomas

    • Eric J. Dozois
    • David J. Jacofsky
    • David W. Larson

    Bone and Soft Tissue Sarcomas 14 December 2010 Pages: 983 - 988

    

16. Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal Cancer

    • Y. Nancy You
    • Halim Habiba
    • John M. Skibber

    Colorectal Cancer 04 December 2010 Pages: 989 - 996

    

17. Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer

    • C. S. D. Roxburgh
    • J. J. Platt
    • D. C. McMillan

    Colorectal Cancer 02 November 2010 Pages: 997 - 1005

18. Clinical Translation of Ex Vivo Sentinel Lymph Node Mapping for Colorectal Cancer Using Invisible Near-Infrared Fluorescence Light

    • Merlijn Hutteman
    • Hak Soo Choi
    • Alexander L. Vahrmeijer

    Colorectal Cancer Open access 16 November 2010 Pages: 1006 - 1014

    

19. Clinicopathological Assessment of Locally Recurrent Rectal Cancer and Relation to Local Re-Recurrence

    • Mamoru Uemura
    • Masataka Ikeda
    • Masaki Mori

    Colorectal Cancer 17 November 2010 Pages: 1015 - 1022

    

20. Prospective Randomized Trial of Ligasure Versus Harmonic Hemostasis Technique in Thyroidectomy

    • Reza Rahbari
    • Aarti Mathur
    • Electron Kebebew

    Endocrine Tumors 12 November 2010 Pages: 1023 - 1027

21. Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid Cancer

    • Emad Kandil
    • Marta M. Gilson
    • Ralph P. Tufano

    Endocrine Tumors 29 October 2010 Pages: 1028 - 1034

    

22. Same-Day Thyroidectomy: A Review of Practice Patterns and Outcomes for 1,168 Procedures in New York State

    • Charles T. Tuggle
    • Sanziana Roman
    • Julie Ann Sosa

    Endocrine Tumors 18 November 2010 Pages: 1035 - 1040

    

23. Shifting Incidence of Solitary Adenomas in the Era of Minimally Invasive Parathyroidectomy. A Multi-Institutional Study

    • Bas A. Twigt
    • Anne M. Vollebregt
    • Inne H. M. Borel Rinkes

    Endocrine Tumors 21 December 2010 Pages: 1041 - 1046

    

24. Common Locations of Parathyroid Adenomas

    • Mauricio A. Moreno
    • Glenda G. Callender
    • Nancy D. Perrier

    Endocrine Tumors 20 November 2010 Pages: 1047 - 1051

    

25. Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Gabriel Glockzin
    • Philipp Renner
    • Pompiliu Piso

    Gastrointestinal Oncology 03 November 2010 Pages: 1052 - 1059

    

26. Comparison of the 6th and 7th Editions of the UICC TNM Staging System for Gastric Cancer: Results of a Chinese Single-Institution Study of 1,503 Patients

    • Wei Wang
    • Xiao-wei Sun
    • Zhi-wei Zhou

    Gastrointestinal Oncology Open access 24 November 2010 Pages: 1060 - 1067

    

27. Macroscopic Serosal Classification Predicts Peritoneal Recurrence for Patients with Gastric Cancer Underwent Potentially Curative Surgery

    • Zhe Sun
    • Ying-ying Xu
    • Hui-mian Xu

    Gastrointestinal Oncology 14 December 2010 Pages: 1068 - 1080

    

28. Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases

    • William Rule
    • Robert Timmerman
    • L. Chinsoo Cho

    Hepatobiliary Tumors 03 November 2010 Pages: 1081 - 1087

    

29. Safety of Liver Resection in the Elderly: How Important Is Age?

    • S. W. Cho
    • J. Steel
    • T. Clark Gamblin

    Hepatobiliary Tumors 03 November 2010 Pages: 1088 - 1095

30. Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases

    • Michael D’Angelica
    • Peter Kornprat
    • William R. Jarnagin

    Hepatobiliary Tumors 02 November 2010 Pages: 1096 - 1103

    

31. Is Delayed Liver Resection Appropriate for Patients with Metachronous Colorectal Metastases?

    • Shinichi Ueno
    • Masahiko Sakoda
    • Shoji Natsugoe

    Hepatobiliary Tumors 03 November 2010 Pages: 1104 - 1109

    

32. Perioperative Intra-Arterial and Systemic Chemotherapy for Pancreatic Cancer

    • Hiroshi Takamori
    • Keiichiro Kanemitsu
    • Hideo Baba

    Pancreatic Tumors 03 November 2010 Pages: 1110 - 1115

    

33. Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease

    • Sherif R. Z. Abdel-Misih
    • Ioannis Hatzaras
    • Mark Bloomston

    Pancreatic Tumors 02 November 2010 Pages: 1116 - 1121

    

34. Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

    • Philip Q. Bao
    • Ramesh K. Ramanathan
    • Herbert J. Zeh III

    Pancreatic Tumors 23 November 2010 Pages: 1122 - 1129

    

35. Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer

    • Yogesh K. Vashist
    • Julian Loos
    • Jakob R. Izbicki

    Thoracic Oncology 28 October 2010 Pages: 1130 - 1138

    

36. Disease-Related Mortality within the First Year after Subtotal Esophagectomy for Cancer

    • Guy Pines
    • Yoram Klein
    • Hanoch Kashtan

    Thoracic Oncology 03 November 2010 Pages: 1139 - 1144

    

37. Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting?

    • Ricardo Mingarini Terra
    • So Yeon Kim
    • Fabio Biscegli Jatene

    Thoracic Oncology 16 December 2010 Pages: 1145 - 1150

    

38. Impact of Elective Versus Imperative Indications on Oncologic Outcomes After Open Nephron-Sparing Surgery for the Treatment of Sporadic Renal Cell Carcinomas

    • Grégoire Coffin
    • Vincent Hupertan
    • Morgan Rouprêt

    Urologic Oncology 07 December 2010 Pages: 1151 - 1157

    

39. Identification of Differentially Expressed MicroRNA in Parathyroid Tumors

    • Reza Rahbari
    • Alisha K. Holloway
    • Electron Kebebew

    Translational Research and Biomarkers 18 November 2010 Pages: 1158 - 1165

    

40. Significance of Lgr5^+ve Cancer Stem Cells in the Colon and Rectum

    • Hidekazu Takahashi
    • Hideshi Ishii
    • Masaki Mori

    Translational Research and Biomarkers 02 December 2010 Pages: 1166 - 1174

    

41. Hepatic Stellate Cells Accelerate the Malignant Behavior of Cholangiocarcinoma Cells

    • Hirohisa Okabe
    • Toru Beppu
    • Hideo Baba

    Translational Research and Biomarkers 02 November 2010 Pages: 1175 - 1184

    

42. Identification and Validation of DNA Methylation Markers to Predict Lymph Node Metastasis of Esophageal Squamous Cell Carcinomas

    • Ken Gyobu
    • Satoshi Yamashita
    • Toshikazu Ushijima

    Translational Research and Biomarkers 02 November 2010 Pages: 1185 - 1194

    

43. Clinical Significance of Melanoma Antigen-Encoding Gene-1 (MAGE-1) Expression and its Correlation with Poor Prognosis in Differentiated Advanced Gastric Cancer

    • Kyoichi Ogata
    • Ryuusuke Aihara
    • Hiroyuki Kuwano

    Translational Research and Biomarkers 02 November 2010 Pages: 1195 - 1203

    

44. Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma

    • Shigeru Ueda
    • Ken Shirabe
    • Yoshihiko Maehara

    Translational Research and Biomarkers 13 November 2010 Pages: 1204 - 1211